Testing a new flu shot in healthy adults
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old
- You are generally in good health
- You have not had the flu or a flu-like illness in the past 6 months
- You have not received a flu shot in the past 6 months
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 3 months
- You do not have serious chronic conditions like heart disease, lung disease, diabetes, or autoimmune disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
This trial tests an experimental flu shot that includes an adjuvant (an ingredient that boosts the immune response). It aims to see if the shot is safe and how well it works in adults. Participation lasts for a few months and involves blood tests and a review of any side effects.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.